# Danish Elder Lymphoma Patient Hematopoietic Investigation

> **NCT05245487** · — · RECRUITING · sponsor: **Rigshospitalet, Denmark** · enrollment: 300 (estimated)

## Conditions studied

- Lymphoma
- Chemotherapy-induced Neutropenia
- Chemotherapy-Related Leukemia
- Chemotherapeutic Toxicity

## Interventions

- **DIAGNOSTIC_TEST:** DNA repair gene mutation analysis

## Key facts

- **NCT ID:** NCT05245487
- **Lead sponsor:** Rigshospitalet, Denmark
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-01-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2035-01-01
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2023-12-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05245487

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05245487, "Danish Elder Lymphoma Patient Hematopoietic Investigation". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT05245487. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*